Major Programs

The Division of Cancer Prevention supports major scientific collaborations, research networks, investigator-initiated grants, postdoctoral training, and specialized resources across the United States.

Alliance of Glycobiologists for Cancer Research

Nine Tumor Glycomics Laboratories working to reveal cancer-related dynamics of complex carbohydrates.

Learn more about the Alliance of Glycobiologists for Cancer Research

Barrett's Esophagus Translational Research Network (BETRNet)

A multi-disciplinary, multi-institutional collaboration to enhance understanding of Barrett's esophagus and to prevent esophageal adenocarcinoma.

Read more about Barrett's Esophagus Translational Research Network (BETRNet)

Cancer Prevention Clinical Trials Network (CP-CTNet)

CP-CTNet performs early phase clinical trials to assess the preventive potential of agents and interventions of varying classes, many of which target molecules and processes known to be important during carcinogenesis.

More about the Cancer Prevention Clinical Trials Network (CP-CTNet)

Cancer Prevention Fellowship Program (CPFP)

Training to form a strong foundation in cancer prevention and control for scientists and clinicians.

See more about the Cancer Prevention Fellowship Program (CPFP)

Consortium for Imaging and Biomarkers (CIB)

Eight lead investigators combining imaging methods for the visualization of lesions with biomarkers to improve the accuracy of screening, early cancer detection, and the diagnosis of early stage cancers.

Learn more about the Consortium for Imaging and Biomarkers (CIB)

Consortium for Molecular Characterization of Screen-Detected Lesions

Seven laboratories and a coordinating center focused on identifying screening-detected pre-cancers and early cancers, including within the tumor microenvironment.

Read more about the Consortium for Molecular Characterization of Screen-Detected Lesions

Early Detection Research Network (EDRN)

Comprehensive infrastructure and resources critical to discovery, development and validation of biomarkers for cancer risk and early detection.

More about the Early Detection Research Network (EDRN)

Liquid Biopsy Consortium

A new, noninvasive technique that can detect disease biomarkers in blood, urine, and sputum.

Learn more about the Liquid Biopsy Consortium

NCI Community Oncology Research Program (NCORP)

A clinical trials network of cancer care professionals who care for diverse populations across the United States.

Learn more about the NCI Community Oncology Research Program (NCORP)

Pancreatic Cancer Detection Consortium (PCDC)

Develops and tests new molecular and imaging biomarkers to detect early stage PDAC and its precursor lesions.

Read more about the Pancreatic Cancer Detection Consortium (PCDC)

Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)

Systematic early clinical development of promising preventive agents through five major medical research centers.

More about the Phase 0/I/II Cancer Prevention Clinical Trials Program (Consortia)

PREVENT Cancer Preclinical Drug Development Program (PREVENT)

Research pipeline for new prevention interventions and biomarkers headed toward clinical trials.

Read more about the PREVENT Cancer Preclinical Drug Development Program (PREVENT)

Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)

A repository of data from a large randomized trial on the effects of screening on cancer-related mortality and secondary endpoints in men and women aged 55 to 74.

Learn more about the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO)

Small Cell Lung Cancer (SCLC) Consortium

Conducting research to expand the understanding of the critical molecular changes in the lung that precede the development of frank SCLC and/or to identify populations at particularly high risk for SCLC.

Learn more about Small Cell Lung Cancer (SCLC) Consortium

Supportive Care and Symptom Management

Examining symptoms and morbidities related to cancer, its treatment, quality of life and end of life.

Read more about Supportive Care and Symptom Management

Translational Liver Cancer (TLC) Consortium

Conducting studies to improve surveillance of liver cancer in high-risk populations, increase detectability at early stages, and stratify at-risk patients.

Learn more about the Translational Liver Cancer (TLC) Consortium

US-Latin American-Caribbean Clinical Trials Network (ULACNet)

ULACNet, proposed to be established through the funding opportunity RFA-CA-18-018, will focus on improving prevention of human papillomavirus (HPV)-related cancers in human immunodeficiency virus (HIV)-infected individuals.

More about the US-Latin American-Caribbean Clinical Trials Network (ULACNet)

Research Networks Map

The Division of Cancer Prevention supports major scientific collaborations and research networks at more than 100 sites across the United States.

View the DCP Research Networks Map